Behandling med Pegasys var ledsaget af fald i de absolutte CD4+ celletal indenfor de første uger uden reduktion i CD4+ celleprocenten.
Pegasys treatment was associated with decreases in absolute CD4+ cell counts within the first 4 weeks without a reduction in CD4+ cell percentage.